Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Lists
Only you see this
Abstract
FVC% has acceptable test-retest reliability, and we have provided the MCID estimates for FVC% in SSc-ILD based changes at 12 months from baseline in two clinical trials. Clinical trial registration available at www.clinicaltrials.gov, IDs NCT00004563 and NCT00883129.
BibTeX
@inproceedings{kafaja2017reliability,
author = {Suzanne Kafaja and Philip J. Clements and Holly Wilhalme and Chi‐Hong Tseng and Daniel E. Furst and Grace Hyun J. Kim and Jonathan Goldin and Elizabeth R. Volkmann and Michael D. Roth and Donald P. Tashkin and Dinesh Khanna and Ann Arbor and Dinesh Khanna and Los Angeles and Philip J. Clements and Donald P. Tashkin and Robert M. Elashoff and Jonathan Goldin and Michael D. Roth and Daniel E. Fürst and Ken J. Bulpitt and Wen Ling Joanie Chung and Sherrie Viasco and Millie Sterz and Lovlette Woolcock and Xiao Yan and John S. Ho and Sarinnapha M. Vasunilashorn and Irene Da Costa and James R. Seibold and D. Riley and J. K. Amorosa and Vivien Hsu and Deborah McCloskey and James Wilson and John Varga and Dean E. Schraufnagel and Andrew C. Wilbur and David Lapota and Shiva Arami and Patricia Cole-Saffold and Robert W. Simms and A. Theodore and Peter Clarke and J H Korn and Katy Tobin and M. Nuite and Richard M. Silver and Marcy B. Bolster and Charlie Strange and Stephen I. Schabel and Edwin A. Smith and Jeanne Arnold and Kathleen L. Caldwell and Michael Bonner and Robert A. Wise and Fredrick M. Wigley and Barbara White and Laura K. Hummers and Mark E. Bohlman and Angelo Polito and G. Leatherman and E. Forbes and Matěj Daniel and Virginia Steen and Cornelia D Read and Christopher S. Cooper and Sean Wheaton and Andrew L. Carey and A. Blandino Ortiz and Maureen D. Mayes and Ed Parsley and Stephanie Oldham and Tan Filemon and S. Jordan and Marilyn Perry and K. Connolly and Jeffrey A. Golden and Paul J. Wolters and Roger T. Webb and J. Michael Davis and Christine Antolos and Carla Maynetto and B. Fessler and Mitchell A. Olman and Caroline Sanders and Louis W. Heck and Tina Parkhill and Naomi F. Rothfield and Mark L. Metersky and Richard Cobb and Macha Aberles and F. Ingenito and Elizabeth C. Breen and Maureen D. Mayes and K.K. Mubarak and J. L. Granda and Joana Silva and Zora Injic and Ronika Alexander},
title = {{Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)}},
booktitle = {American},
year = {2017},
doi = {10.1164/rccm.201709-1845oc},
}Loading related content...